<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00746161</url>
  </required_header>
  <id_info>
    <org_study_id>WMU-GC02</org_study_id>
    <nct_id>NCT00746161</nct_id>
  </id_info>
  <brief_title>Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer</brief_title>
  <official_title>A Prospective Randomized Controlled Trial Comparing Double Tract Method With Roux-en-Y Method After Total Gastrectomy in Patients With Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wakayama Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wakayama Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the double tract reconstruction after total
      gastrectomy in patients with gastric cancer. A prospective randomized controlled trial was
      conducted to compare double tract method with Roux-en-Y method
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with gastric cancer were intraoperatively randomized for R-Y reconstruction or DT
      reconstruction after total gastrectomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2002</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The %body weight ratio</measure>
    <time_frame>12 months after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>preoperative complication, PNI and QOL score</measure>
    <time_frame>within one month, and 3 and 12months after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Roux-en-Y</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>double tract reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reconstruction after total gastrectomy</intervention_name>
    <description>Roux-en-Y</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reconstruction after total gastrectomy</intervention_name>
    <description>double tract reconstruction</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically proven adenocarcinoma without esophageal invasion, tumor status T1-2

          -  Age 80 years or younger

          -  No distant metastasis

        Exclusion Criteria:

          -  Carcinoma in the remnant stomach

          -  Stage intravenous (IV)

          -  History of laparotomy

          -  History of serious heart disease

          -  Liver cirrhosis or chronic liver disease with indocyanine green excretion test at 15
             min of 15% or more

          -  Absence of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Makoto Iwahashi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Department of Surgery, Wakayama Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Second Department of Surgery, Wakayama Medical University</name>
      <address>
        <city>Wakayama</city>
        <zip>641-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2008</study_first_submitted>
  <study_first_submitted_qc>September 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2008</study_first_posted>
  <last_update_submitted>September 3, 2008</last_update_submitted>
  <last_update_submitted_qc>September 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2008</last_update_posted>
  <responsible_party>
    <name_title>Second Department of Surgery</name_title>
    <organization>Wakayama Medical University</organization>
  </responsible_party>
  <keyword>total gastrectomy</keyword>
  <keyword>double tract reconstruction</keyword>
  <keyword>gastric cancer</keyword>
  <keyword>Total gastrectomy in patients with gastric cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

